Each manufacturer must establish a procedure for recalling medical cannabis that has a reasonable probability of causing an unexpected or harmful response in a patient population, despite appropriate use, that outweighs the potential benefit of the medication. This procedure must include:
factors that make a recall necessary;
manufacturer's personnel who are responsible for overseeing the recall; and
how to notify affected parties of a recall.
40 SR 1599
June 20, 2016